483 related articles for article (PubMed ID: 15489652)
21. Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor.
Al-Hussaini M; Hirschowitz L; McCluggage WG
Int J Gynecol Pathol; 2008 Apr; 27(2):236-42. PubMed ID: 18317218
[TBL] [Abstract][Full Text] [Related]
22. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
Rekhi B; Vogel U
APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
[TBL] [Abstract][Full Text] [Related]
23. Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: immunohistochemical and DNA direct sequencing analysis.
Kinoshita Y; Shiratsuchi H; Tamiya S; Oshiro Y; Hachitanda Y; Oda Y; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2001; 127(6):351-8. PubMed ID: 11414195
[TBL] [Abstract][Full Text] [Related]
24. Pediatric extra-renal rhabdoid tumors with unusual morphology: a diagnostic pitfall for small biopsies.
Alaggio R; Boldrini R; Di Venosa B; Rosolen A; Bisogno G; Magro G
Pathol Res Pract; 2009; 205(7):451-7. PubMed ID: 19243895
[TBL] [Abstract][Full Text] [Related]
25. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis.
Li L; Fan XS; Xia QY; Rao Q; Liu B; Yu B; Shi QL; Lu ZF; Zhou XJ
Hum Pathol; 2014 Nov; 45(11):2247-54. PubMed ID: 25200863
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of SMARCB1/INI1 protein in synovial sarcoma.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Matono H; Iwamoto Y; Taguchi T; Tsuneyoshi M
Mod Pathol; 2010 Jul; 23(7):981-90. PubMed ID: 20305614
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
[TBL] [Abstract][Full Text] [Related]
28. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
[TBL] [Abstract][Full Text] [Related]
29. Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviour.
Wu X; Dagar V; Algar E; Muscat A; Bandopadhayay P; Ashley D; Wo Chow C
Pathology; 2008 Dec; 40(7):664-70. PubMed ID: 18985520
[TBL] [Abstract][Full Text] [Related]
30. Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility.
Kim HJ; Kim MH; Kwon J; Kim JY; Park K; Ro JY
Ann Diagn Pathol; 2012 Oct; 16(5):411-5. PubMed ID: 21724432
[TBL] [Abstract][Full Text] [Related]
31. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.
Kuwahara Y; Wei D; Durand J; Weissman BE
Mol Cancer Res; 2013 Mar; 11(3):251-60. PubMed ID: 23364536
[TBL] [Abstract][Full Text] [Related]
32. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.
Fujisawa H; Takabatake Y; Fukusato T; Tachibana O; Tsuchiya Y; Yamashita J
J Neurooncol; 2003 Jul; 63(3):257-62. PubMed ID: 12892231
[TBL] [Abstract][Full Text] [Related]
33. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium.
Donner LR; Wainwright LM; Zhang F; Biegel JA
Hum Pathol; 2007 Jun; 38(6):935-9. PubMed ID: 17376508
[TBL] [Abstract][Full Text] [Related]
34. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.
Biegel JA; Fogelgren B; Wainwright LM; Zhou JY; Bevan H; Rorke LB
Genes Chromosomes Cancer; 2000 May; 28(1):31-7. PubMed ID: 10738300
[TBL] [Abstract][Full Text] [Related]
35. Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.
Kohashi K; Yamamoto H; Kumagai R; Yamada Y; Hotokebuchi Y; Taguchi T; Iwamoto Y; Oda Y
Mod Pathol; 2014 Jun; 27(6):832-9. PubMed ID: 24287458
[TBL] [Abstract][Full Text] [Related]
36. Rhabdoid tumor of the kidney is a component of the rhabdoid predisposition syndrome.
Lee HY; Yoon CS; Sevenet N; Rajalingam V; Delattre O; Walford NQ
Pediatr Dev Pathol; 2002; 5(4):395-9. PubMed ID: 12016529
[TBL] [Abstract][Full Text] [Related]
37. No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors.
Zhang F; Tan L; Wainwright LM; Bartolomei MS; Biegel JA
Genes Chromosomes Cancer; 2002 Aug; 34(4):398-405. PubMed ID: 12112529
[TBL] [Abstract][Full Text] [Related]
38. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.
Perry A; Fuller CE; Judkins AR; Dehner LP; Biegel JA
Mod Pathol; 2005 Jul; 18(7):951-8. PubMed ID: 15761491
[TBL] [Abstract][Full Text] [Related]
39. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
Caramel J; Medjkane S; Quignon F; Delattre O
Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
[TBL] [Abstract][Full Text] [Related]
40. Congenital Disseminated Extrarenal Malignant Rhabdoid Tumor.
Boudjemaa S; Petit A; Dainese L; Bourdeaut F; Lipsett J; Coulomb A
Pediatr Dev Pathol; 2015; 18(5):401-4. PubMed ID: 25751458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
